Found: 13
Select item for more details and to access through your institution.
Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 2, p. 359, doi. 10.1007/s10549-019-05482-8
- By:
- Publication type:
- Article
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.
- Published in:
- Science Signaling, 2019, v. 12, n. 595, p. 1, doi. 10.1126/scisignal.aas8779
- By:
- Publication type:
- Article
Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosisc.
- Published in:
- FEBS Journal, 2005, v. 272, n. 16, p. 4091, doi. 10.1111/j.1742-4658.2005.04821.x
- By:
- Publication type:
- Article
Orchestrated expression of vasculogenic mimicry and laminin‐5γ2 is an independent prognostic marker in oral squamous cell carcinoma.
- Published in:
- International Journal of Experimental Pathology, 2022, v. 103, n. 2, p. 54, doi. 10.1111/iep.12430
- By:
- Publication type:
- Article
Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional lymph node metastasis by alterations of SDF1α/CXCR4 axis.
- Published in:
- International Journal of Experimental Pathology, 2021, v. 102, n. 2, p. 80, doi. 10.1111/iep.12386
- By:
- Publication type:
- Article
Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 4, p. 493, doi. 10.1002/ijc.1624
- By:
- Publication type:
- Article
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6139, doi. 10.1038/ncomms7139
- By:
- Publication type:
- Article
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6169, doi. 10.1038/ncomms7169
- By:
- Publication type:
- Article
Mechanistic profiling of phytochemical as anti-cancer agent against multiple clinically aggressive cancers.
- Published in:
- Journal of Cancer Research & Therapeutics, 2017, v. 13, p. S452
- By:
- Publication type:
- Article
Prediction of anticancer drug response in an adjuvant clinical setting for breast cancers by ex vivo live tumor phenotypic assay platform.
- Published in:
- Journal of Cancer Research & Therapeutics, 2017, v. 13, p. S452
- By:
- Publication type:
- Article
Mechanistic Profiling Of Phytochemical As Anti-Cancer Agent Against Multiple Clinically Aggressive Cancers.
- Published in:
- Journal of Cancer Research & Therapeutics, 2017, v. 13, p. S177
- By:
- Publication type:
- Article
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer.
- Published in:
- Cellular Oncology (2211-3428), 2017, v. 40, n. 2, p. 145, doi. 10.1007/s13402-016-0311-7
- By:
- Publication type:
- Article
Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1414376
- By:
- Publication type:
- Article